E115: Are We All Gamblers Now? + Why Market Valuations (P/E) Are Fake Podcast Por  arte de portada

E115: Are We All Gamblers Now? + Why Market Valuations (P/E) Are Fake

E115: Are We All Gamblers Now? + Why Market Valuations (P/E) Are Fake

Escúchala gratis

Ver detalles del espectáculo
🎰 The Degeneracy Trap – Is the economy forcing investors into a casino mindset? We dissect the viral debate on "financial nihilism" and why the pressure to get rich quick is destroying portfolios.💪 Skills vs Luck – The antidote to social media envy. Why compounding your skillset is the only reliable hedge against inflation, stagnant wages, and the housing crisis.📊 The P/E Ratio Myth – Why looking at historical P/E ratios might be costing you money. We break down how accounting rule changes and stock-based comp have distorted the "market is overvalued" narrative.⚡ Selling Winners? – Luke explains the painful but necessary decision to trim his Axon position. A deep dive into Price-to-Gross-Profit reveals why a 32x multiple signaled it was time to take chips off the table.💄 Oddity: The New King of the Jungle – Krzysztof unveils his latest portfolio addition. See how combining patience, technical analysis, and fundamental strength led to the perfect entry point.📉 Options Mistakes & Lessons – We strip back the ego and discuss our recent losses with Cipher and Quantum Computing. Learn why paying too much for volatility or misjudging the clock can zero out your returns.🎓 The Alpha Strategy – A sneak peek into the upcoming Patreon Options Course. Krzysztof reveals advanced strategies, including how to sell calls against purchased options to lower your cost basis.💊 Novo Nordisk's Pivot – The community portfolio's top pick is up 34%, but the run might just be starting. We discuss the massive implications of weight-loss drugs moving from injections to oral pills.Sources:Degeneracy Post and Response:https://x.com/systematicls/status/2004900241745883205https://x.com/JaredKubin/status/2006028297688297475The Broken Yardstick, why historical Price-to-Earnings (P/E) comparisons are fundamentally flawed:https://manuinvests.substack.com/p/the-broken-yardstick-why-your-historicSegments:00:00 Introduction: Patience vs Degeneracy02:11 Krzysztof's Options Course Marathon03:30 Ski Season Begins & One Battle After Another07:22 Degeneracy Debate: Are We Becoming Gamblers?11:47 The Case for Compounding Skills16:50 Rejecting Social Media Comparison Culture20:23 Asset Bubbles & Historical Context24:25 PE Ratios: Why Historical Comparisons Fail34:38 Axon Enterprise Valuation Analysis42:16 Oddity: Monkey's Latest Addition50:20 Combining Fundamentals with Technicals51:59 Options Timing: The Critical Variable56:10 Cipher Options Error & Strategy Missed01:00:47 Options Course Beta Testing Announcement01:03:23 Novo Nordisk & Oral Weight Loss Drugs**********If you want to see our furry faces, this podcast is also available on YouTube at ⁠https://www.youtube.com/@WallStreetWildlife?sub_confirmation=1⁠**********SUPPORT THE SHOW AND BECOME A PATREON:https://wallstreetwildlife.com**********Follow us at:⁠⁠x.com/7LukeHallard⁠x.com/7FlyingPlatypus**********Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.Get 15% off any premium plan with:https://fiscal.ai/wildlife**********Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation**********Fed up with the stock market giving you a hard time?- Invest like seasoned pros with over 40 years in the game- Discover the world's leading companies- Sharpen your best investing practices and ditch the worst- Learn how to start investing- Essential investing principles to boost your returnsKeywordsInvesting Psychology, Financial Nihilism, Stock Market Gambling, Axon Enterprise Stock Analysis, ODD Stock, Oddity Tech, Novo Nordisk Stock, PE Ratio Explained, Is the Market Overvalued, Options Trading Mistakes, Technical Analysis Strategy, Compounding Wealth, Wall Street Wildlife
Todavía no hay opiniones